Colistin-loaded silk membranes against wound infection with Pseudomonas aeruginosa

Plastic and Reconstructive Surgery

Volumn 127, Issue 5, 2011, Pages 1838-1846

  Steinstraesser, Lars ^a,b   Trust, Galina ^a,b   Rittig, Andrea ^a,b   Hirsch, Tobias ^a,b   Kesting, Marco R ^a,b   Steinau, Hans Ulrich ^a,b   Jacobsen, Frank ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOMATERIAL; COLISTIN;

ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; BANDAGE; BURN; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; SILK; SPRAGUE DAWLEY RAT; STEM CELL; TREATMENT OUTCOME; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BANDAGES; BURNS; COATED MATERIALS, BIOCOMPATIBLE; COLISTIN; DISEASE MODELS, ANIMAL; MEMBRANES, ARTIFICIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, SPRAGUE-DAWLEY; SILK; STEM CELLS; TREATMENT OUTCOME; WOUND INFECTION;

EID: 79955665198     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31820cf29a     Document Type: Article

References (25)

1. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release 2008;130:202-215.
2. Bowler PG. Wound pathophysiology, infection and therapeutic options. Ann Med. 2002;34:419-427. (Pubitemid 36026773)
3. Giamarellou H. Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother. 2002;49:229-233. (Pubitemid 34162610)
4. Kipnis E, Sawa T, Wiener-Kronish J. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect. 2006; 36:78-91. (Pubitemid 43294628)
5. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother. 2005;55:143-149. (Pubitemid 40331137)
6. Suzuki T, Hayashi K, Fujikawa K, Tsukamoto K. The chemical structure of polymyxin E: The identities of polymyxin E1 with colistin A and of polymyxin E2 with colistin B. J Biochem.1965;57:226-227.
7. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333-1341. (Pubitemid 40570245)
8. Ganapathy H, Pal SK, Teare L, Dziewulski P. Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit. Burns 2010;36:522-527.
9. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gramnegative bacteria. Int J Antimicrob Agents 2005;25:11-25. (Pubitemid 40023341)
10. White RR IV, Pitzer KD, Fader RC, Rajab MH, Song J. Pharmacokinetics of topical and intravenous cefazolin in patients with clean surgical wounds. Plast Reconstr Surg. 2008;122:1773-1779.
11. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: A review. J Pharm Sci. 2008;97:2892-2923.
12. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006; 27:2450-2467. (Pubitemid 41821824)
13. Altman GH, Diaz F, Jakuba C, et al. Silk-based biomaterials. Biomaterials 2003;24:401-416. (Pubitemid 35291198)
14. Sobajo C, Behzad F, Yuan XF, Bayat A. Silk: A potential medium for tissue engineering. Eplasty 2008;8:e47.
15. Jacobsen F, Baraniskin A, Mertens J, et al. Activity of histone H1.2 in infected burn wounds. J Antimicrob Chemother. 2005;55:735-741. (Pubitemid 40691854)
16. Steinstraesser L, Vranckx JJ, Mohammadi-Tabrisi A, et al. A novel titanium wound chamber for the study of wound infections in pigs. Comp Med. 2006;56:279-285. (Pubitemid 44299969)
17. Panilaitis B, Altman GH, Chen J, Jin HJ, Karageorgiou V, Kaplan DL. Macrophage responses to silk. Biomaterials 2003; 24:3079-3085. (Pubitemid 36944938)
18. Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 2004;25:1289-1297. (Pubitemid 37476206)
19. Roh DH, Kang SY, Kim JY, et al. Wound healing effect of silk fibroin/alginate-blended sponge in full thickness skin defect of rat. J Mater Sci Mater Med. 2006;17:547-552.
20. Minoura N, Aiba S, Gotoh Y, Tsukada M, Imai Y. Attachment and growth of cultured fibroblast cells on silk protein matrices. J Biomed Mater Res. 1995;29:1215-1221.
21. Kang M, Jung R, Kim HS, Youk JH, Jin HJ. Silver nanoparticles incorporated electrospun silk fibers. J Nanosci Nanotechnol. 2007;7:3888-3891.
22. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines. J Clin Microbiol. 2001;39: 183-190. (Pubitemid 32059588)
23. Owen RJ, Li J, Nation RL, Spelman D. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother. 2007;59:473-477. (Pubitemid 47073453)
24. White R, Friedrich L, Burgess D, Warkentin D, Bosso J. Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1996;40:904-908. (Pubitemid 26115223)
25. Falagas ME, Rafailidis PI. Re-emergence of colistin in today's world of multidrug-resistant organisms: Personal perspectives. Expert Opin Investig Drugs 2008;17: 973-981.